Ambarish is a partner in the Banking and Finance division in the firm's London office. He focuses primarily on domestic and cross-border syndicated credit, acquisition finance and other leveraged finance transactions.
Ambarish regularly serves as counsel to private equity sponsors and their portfolio companies in acquisition financings, bank and bridge loan financings, unitranche facilities and refinancings and other leveraged finance transactions at all levels of the capital structure. He also advises financial institutions and private investment funds on a wide range of complex cross-border financing transactions including direct lender transactions.
Experience & expertise
Selected matters
- Flexpoint on the financing aspects of its portfolio company AFH including upsize and A&E
- Nexthink on a £100 million RCF provided by HSBC
- Barclays on providing an RCF to Abry-backed Chambers & Partners
- Heritage on financing aspects on a number of investments
- Three Hills on the financing aspects of its investment in WPI including an amend and extend; and subsequent exit
- Barclays on providing financing to Bain Capital-backed Aptia Group
- Barclays on providing financing in connection with HIG's acquisition of DX Group plc
- Acacia in respect of its investment in AMO Pharma
- Blackstone on the non-US elements of the financing of its acquisition of a majority stake in Emerson’s Climate Technologies business – a deal valuing the business at US$14 billion
- Thoma Bravo on financing aspects of its take-private acquisition of Mercell
- Thoma Bravo on financing aspects of its take-private acquisition of Sophos
- Triton on financing aspects of its acquisition of Atnahs (rebranded Pharmanovia)
- Triton on financing aspects of its acquisition and business combination of AVS, Ramudden, Fero and Chevron (rebranded Work Zone Safety Group)
- EW Healthcare on financing aspects of its acquisition of Laboratoires Majorelle
- TDR on financing aspects of its acquisition of BPP University
- Triton on financing aspects of the consensual restructuring of its portfolio company Arvos
- EW Healthcare on financing aspects of its portfolio company EUSA Pharma and subsequent sale to Recordati
- TDR on financing aspects of its portfolio company NKD Deutschland
- TDR on financing aspects of its portfolio company Modulaire and subsequent sale to Brookfield
- Nortonlifelock on its take-private acquisition of Avast plc
- Noble Group on financing aspects of its second restructuring
- EP Investments on various margin loan transactions
Sectors
